Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / NVS - IPO Update: Ayala Pharmaceuticals Launches IPO

NVS - IPO Update: Ayala Pharmaceuticals Launches IPO

Novartis AG

Quick Take

Ayala Pharmaceuticals (AYLA) intends to raise $50 million from an IPO of its common stock, according to an amended registration statement.

The company is advancing a pipeline of drug candidates for the treatment of various cancer conditions.

AYLA has produced promising results for its lead candidate and has a commercial collaboration for its second candidate.

For life science investors with a patient hold time frame, the IPO looks reasonably priced.

Company & Technology

Rehovot, Israel-based Ayala was founded to to develop treatments for various cancers:

  • Recurrent/Metastatic Adenoid Cystic Carcinoma

  • Triple

Read more ...
Stock Information
Company Name: Novartis AG
Stock Symbol: NVS
Market: NYSE
Website: novartis.com
Menu
NVS NVS Quote NVS Short NVS News NVS Articles NVS Message Board
Get NVS Alerts

News, Short Squeeze, Breakout and More Instantly...